When is it appropriate to prescribe intravenous iron supplementation for a patient with end‑stage kidney disease (CKD stage 5) who has low serum iron and low ferritin?

Immediate Intravenous Iron Supplementation is Appropriate Now

With a ferritin of 10 ng/mL and low serum iron in a CKD stage 5 patient, intravenous iron should be initiated immediately—this patient has severe absolute iron deficiency that requires urgent correction. 1

Iron Deficiency Criteria in CKD Stage 5

Your patient meets clear criteria for absolute iron deficiency in end-stage kidney disease:

• Ferritin <100 ng/mL (yours is 10 ng/mL—severely depleted)
• Low serum iron
• These values indicate essentially absent iron stores 1

The NKF-K/DOQI guidelines explicitly define absolute iron deficiency in CKD patients as ferritin <100 ng/mL, and your patient's ferritin of 10 ng/mL represents profound depletion requiring immediate intervention 1.

Recommended Treatment Protocol

Initial Loading Phase

Administer 100-125 mg of IV iron at each hemodialysis session for 8-10 consecutive doses (total 800-1,250 mg over 8-10 weeks). 1

Specific options include:

• Iron dextran: 100 mg weekly for 10 weeks
• Iron gluconate: 125 mg weekly for 8 weeks
• Iron sucrose: 100 mg per session

After Initial Course

• Recheck transferrin saturation (TSAT) and ferritin 2-7 days after the last dose 1
• If TSAT remains <20% and/or ferritin <100 ng/mL, repeat another full course of IV iron (100-125 mg weekly for 8-10 weeks) 1

Maintenance Phase

Once TSAT ≥20% and ferritin ≥100 ng/mL are achieved:

• Continue 25-125 mg IV iron weekly to maintain adequate stores 1
• Provide 250-1,000 mg iron within each 12-week period 1
• Monitor TSAT and ferritin every 3 months 1

Why Intravenous Over Oral Iron

Oral iron is not indicated for CKD stage 5 patients. 1 The evidence is unequivocal:

• Oral iron fails to maintain adequate iron stores in hemodialysis patients, even at doses of 200 mg elemental iron daily 1
• Gastrointestinal absorption is severely impaired in ESKD 1, 2
• Blood losses from dialysis (30-50 mL per session) exceed what oral iron can replace 1
• Elevated hepcidin levels in CKD block intestinal iron absorption 2

Studies show that most hemodialysis patients require regular IV iron to maintain hemoglobin 11-12 g/dL, and oral iron simply cannot achieve this 1.

Clinical Rationale for Immediate Treatment

With ferritin at 10 ng/mL, this patient has:

1. Essentially zero iron stores (normal stores are 800-1,200 mg) 1
2. High risk of persistent severe anemia with increased morbidity and mortality 1
3. Inability to respond adequately to erythropoiesis-stimulating agents (ESAs) if started, since erythropoiesis requires both iron and erythropoietin 1

The guidelines emphasize that oral iron fails to maintain adequate iron stores in most hemodialysis patients, resulting in persistence of moderate anemia, which increases morbidity and mortality 1.

Safety Monitoring

First Dose Precautions

• For iron dextran: Mandatory 25 mg test dose, then monitor for 60 minutes with resuscitative equipment available 1, 3
• For non-dextran formulations (gluconate, sucrose): Monitor for 60 minutes after initial dose 3

Upper Safety Limits

Withhold IV iron if:

• TSAT >50% AND/OR
• Ferritin >800 ng/mL 1

When these thresholds are exceeded, hold iron for up to 3 months, recheck parameters, then resume at reduced dose (one-third to one-half previous dose) 1.

Common Pitfall to Avoid

Do not wait to check TSAT before starting treatment. With ferritin at 10 ng/mL, TSAT will almost certainly be <20%, and this patient has clear absolute iron deficiency requiring immediate IV iron regardless of TSAT value 1. Delaying treatment to obtain additional labs only prolongs the patient's iron-deficient state and associated risks.

The evidence shows that patients with ferritin <200 ng/mL have the best positive predictive value (76%) for responding to parenteral iron with clinically significant reductions in ESA requirements 4. Your patient with ferritin of 10 ng/mL will almost certainly benefit dramatically from IV iron supplementation.